Superfractionation as a potential hypoxic cell radiosensitizer: Prediction of an optimum dose per fraction

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 5, 1999, Pages 1083-1094

  Daşu, Alexandru ^a   Denekamp, Juliana ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Computer modeling; Hyperfractionation; Inducible repair; Linear quadratic model; Oxygen enhancement ratio; Radiosensitization; Tumor resistance

Indexed keywords

ARTICLE; CELL HYPOXIA; CELL REGENERATION; COMPUTER MODEL; COMPUTER SIMULATION; HYPOXIC CELL; OXYGEN ENHANCEMENT RATIO; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; RADIOSENSITIZATION; STATISTICAL MODEL; SURVIVAL RATE; TUMOR RESISTANCE;

CELL HYPOXIA; CELL LINE; CELL SURVIVAL; COMPUTER SIMULATION; DOSE FRACTIONATION; LINEAR MODELS; MODELS, BIOLOGICAL; RADIATION TOLERANCE; RADIOBIOLOGY;

EID: 0345129983     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00471-4     Document Type: Article

References (58)

1. Daşu A., Denekamp J. New insights into factors influencing the clinically relevant oxygen enhancement ratio. Radiother Oncol. 46:1998;269-277.
2. Fowler J.F., Stern B.E. Dose-rate effects Some theoretical and practical considerations . Br J Radiol. 33:1960;389-395.
3. Wheldon T.E., Kirk J. Mathematical derivation of optimal treatment schedules for the radiotherapy of human tumours. Fractionated irradiation of exponentially growing tumours. Br J Radiol. 49:1976;441-449.
4. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
5. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 23:1984;379-391.
6. Dale R.G. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day. Br J Radiol. 59:1986;919-927.
7. Scott O.C.A. Mathematical models of repopulation and reoxygenation in radiotherapy. Br J Radiol. 63:1990;821-823.
8. Fowler J.F. Modelling altered fractionation schedules. Br J Radiol Suppl. 24:1992;187-192.
9. Thames H.D., Schultheiss T.E., Hendry J.H., Tucker S.L., Dubray B.M., Brock W.A. Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys. 22:1992;241-246.
10. Brenner D.J. Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys. 26:1993;171-179.
11. Jones B., Tan L.T., Dale R.G. Derivation of the optimum dose per fraction from the linear quadratic model. Br J Radiol. 68:1995;894-902.
12. Källman P., Lind B.K., Brahme A. An algorithm for maximizing the probability of complication-free tumour control in radiation therapy. Phys Med Biol. 37:1992;871-890.
13. Mohan R., Mageras G.S., Baldwin B., Brewster L.J., Kutcher G.J., Leibel S., Burman C.M., Ling C.C., Fuks Z. Clinically relevant optimization of 3-D conformal treatments. Med Phys. 19:1992;933-944.
14. Webb S. Optimizing the planning of intensity-modulated radiotherapy. Phys Med Biol. 39:1994;2229-2246.
15. Joiner M.C., Denekamp J., Maughan R.L. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. Int J Radiat Biol. 49:1986;565-580.
16. Joiner M.C., Johns H. Renal damage in the mouse The response to very small doses per fraction . Radiat Res. 114:1988;385-398.
17. Beck-Bornholdt H.-P., Maurer T., Becker S., Omniczynski M., Vogler H., Würschmidt F. Radiotherapy of the rhabdomyosarcoma R1H of the rat Hyperfractionation-126 fractions applied within 6 weeks . Int J Radiat Oncol Biol Phys. 16:1989;701-705.
18. Marples B., Joiner M.C., Skov K.A. An X-ray inducible repair response Evidence from high resolution survival measurements in air and hypoxia . Sugahara T., Sagan L.A., Aoyama T. Low dose irradiation and biological defense mechanisms. 1992;295-298 Elsevier, Amsterdam.
19. Wouters B.G., Skarsgard L.D. The response of a human tumor cell line to low radiation doses Evidence of enhanced sensitivity . Radiat Res. 138:1994;S76-S80.
20. Singh B., Arrand J.E., Joiner M.C. Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int J Radiat Biol. 65:1994;457-464.
21. Lambin P., Malaise E.P., Joiner M.C. Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiat Biol. 69:1996;279-290.
22. Marples B., Adomat H., Koch C.J., Skov K.A. Response of V79 cells to low doses of X-rays and negative π-mesons Clonogenic survival and DNA strand breaks . Int J Radiat Biol. 70:1996;429-436.
23. Wouters B.G., Sy A.M., Skarsgard L.D. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat Res. 146:1996;399-413.
24. Hamilton C.S., Denham J.W., O'Brien M., Ostwald P., Kron T., Wright S., Dörr W. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol. 40:1996;23-30.
25. Joiner M.C., Lambin P., Malaise E.P., Robson T., Arrand J.E., Skov K.A., Marples B. Hypersensitivity to very-low single radiation doses Its relationship to the adaptive response and induced radioresistance . Mutat Res. 358:1996;171-183.
26. Skarsgard L.D., Wilson D.J., Durand R.E. Survival at low dose in asynchronous and partially synchronized Chinese hamster V79-171 cells. Radiat Res. 133:1993;102-107.
27. Skarsgard L.D., Skwarchuk M.W., Wouters B.G., Durand R.E. Substructure in the radiation survival response at low dose in cells of human tumor cell lines. Radiat Res. 146:1996;388-398.
28. Skarsgard L.D., Wouters B.G. Substructure in the cell survival response at low radiation dose Effect of different subpopulations . Int J Radiat Biol. 71:1997;737-749.
29. Wouters B.G., Skarsgard L.D. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells. Radiat Res. 148:1997;435-442.
30. Calkins J. An unusual form of response in X-irradiated protozoa and a hypothesis as to its origin. Int J Radiat Biol. 12:1967;297-301.
31. Koval T.M. Multiphasic survival response of a radioresistant lepidopteran insect cell line. Radiat Res. 98:1984;642-648.
32. Calkins J., Einspenner M., Blocher D., Greer W. Responses of two mammalian cell lines to low gamma-ray doses. Int J Radiat Biol. 56:1989;869-875.
33. Alsbeih G, Raaphorst GP. Radiosensitive human cells at the crossroads: High split-dose recovery and diminished inducible response. Radiation Research Society Meeting 1997 (poster abstract).
34. Littbrand B. Survival characteristics of mammalian cell lines after single or multiple exposures to roentgen radiation under oxic or anoxic conditions. Acta Radiol Ther Phys Biol. 9:1970;257-281.
35. Littbrand B., Edsmyr F., Révész L. A low dose-fractionation scheme for the radiotherapy of carcinoma of the bladder. Experimental background and preliminary results. Bull Cancer. 62:1975;241-248.
36. Marples B., Joiner M.C. The response of Chinese hamster V79 cells to low radiation doses Evidence of enhanced sensitivity of the whole cell population . Radiat Res. 133:1993;41-51.
37. Marples B., Joiner M.C., Skov K.A. The effect of oxygen on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79-379A cells. Radiat Res. 138:1994;S17-S20.
38. Whitmore GF, Gulyas S, Denekamp J. 1987 (unpublished).
39. Denekamp J., Whitmore G.F., Jeggo P. Biphasic survival curves for XRS radiosensitive cells Subpopulations or transient expression of repair competence? Int J Radiat Biol. 55:1989;605-617.
40. Littbrand B., Révész L. The effect of oxygen on cellular survival and recovery after radiation. Br J Radiol. 42:1969;914-924.
41. Chapman J.D., Gillespie C.J., Reuvers A.P., Dugle D.L. The inactivation of Chinese hamster cells by x rays The effects of chemical modifiers on single- and double-events . Radiat Res. 64:1975;365-375.
42. Palcic B., Brosing J.W., Skarsgard L.D. Survival measurements at low doses oxygen enhancement ratio . Br J Cancer. 46:1982;980-984.
43. Palcic B., Skarsgard L.D. Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiat Res. 100:1984;328-339.
44. Pettersen E.O., Christensen T., Bakke O., Oftebro R. A change in the oxygen effect throughout the cell-cycle of human cells of the line NHIK 3025 cultivated in vitro. Int J Radiat Biol. 31:1977;171-184.
45. Pettersen E.O., Wang H. Radiation-modifying effect of oxygen in synchronized cells pretreated with acute or prolonged hypoxia. Int J Radiat Biol. 70:1996;319-326.
46. Skarsgard L.D., Harrison I. Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. Radiat Res. 127:1991;243-247.
47. Watts M.E., Hodgkiss R.J., Jones N.R., Fowler J.F. Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low X-ray doses. Int J Radiat Biol. 50:1986;1009-1021.
48. Hall E.J. Radiobiology for the radiologist, 4th ed. 1994;J.B. Lippincott, Philadelphia.
49. Kellerer A.M., Rossi H.H. RBE and the primary mechanism of radiation action. Radiat Res. 47:1971;15-34.
50. Chadwick K.H., Leenhouts H.P. A molecular theory of cell survival. Phys Med Biol. 18:1973;78-87.
51. Douglas B.G., Fowler J.F. Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol. 48:1975;502-504.
52. Denekamp J., Daşu A., Waites A., Littbrand B. Hyperfractionation as an effective way of overcoming radioresistance. Int J Radiat Oncol Biol Phys. 42:1998;705-709.
53. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
54. Horiot J.C., Le Fur R., N'Guyen T., Chenal C., Schraub S., Alfonsi S., Gardani G., Van Den Bogaert W., Danczak S., Bolla M., Van Glabbeke M., De Pauw M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
55. Edsmyr F., Andersson L., Esposti P.L., Littbrand B., Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol. 4:1985;197-203.
56. Näslund I., Nilsson B., Littbrand B. Hyperfractionated radio-therapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol. 33:1994;397-402.
57. Fein D.A., Morgan L.S., Marcus R.B. Jr, Mendenhall W.M., Sombeck M.D., Freeman D.E., Million R.R. Stage III ovarian carcinoma An analysis of treatment results and complications following hyperfractionated abdominopelvic irradiation for salvage . Int J Radiat Oncol Biol Phys. 29:1994;169-176.
58. Maher E.J., Timothy A., Squire C.J., Goodman A., Karp S.J., Paine C.H., Ryall R., Read G. Audit The use of radiotherapy for NSCLC in the UK . Clin Oncol. 5:1993;72-79.